Patient and Prescriber Survey: Effectiveness measures to investigate awareness, knowledge and adherence to the Risk Minimisation Measures (RMMs) of the Pregnancy Prevention Program (PPP) for Oral Retinoids (Acitretin, Alitretinoin, and Isotretinoin)

First published 16/11/2020

Last updated 28/02/2024

EU PAS number:

EUPAS38096

Study

Finalised

Documents

Study protocol

Initial protocol

20200727_Oral Retinoids_PASS_Survey_Protocol_v5.0_Redacted_NO ANNEX

English (2.71 MB - PDF) View document

Study results

38096_20220215 Oral Retinoids_PASS_Survey_Final Report_v1.0_Abstract

English (228.94 KB - PDF) View document

Study report

Other information

Secondary tabs